Probiotics are living microorganisms that improve health when eaten or introduced to the
body. They have become an essential aspect of everyone's life now due to these products …

Clostridium difficile is a leading cause of morbidity and mortality particularly in hospital
settings. In addition, treatment is very challenging due to the scarcity of effective therapeutic …

In people, colonization with Clostridioides difficile, the leading cause of antibiotic-associated
diarrhea, has been shown to be associated with distinct gut microbial features, including …

Clostridium difficile (C. difficile) is rapidly becoming one of the most prevalent health care–
associated bacterial infections in the developed world. The emergence of new, more virulent …

The interplay between human health and the microbiome has gained extensive attention,
with probiotics emerging as pivotal therapeutic agents due to their vast potential in treating …

Approximately 30% of patients who have Clostridioides difficile infection (CDI) will suffer at
least one incident of reinfection. While the underlying causes of CDI recurrence are poorly …

Outbreaks of viral diseases are on the rise, fueling the search for antiviral therapeutics that
act on a broad range of viruses while remaining safe to human host cells. In this research …

Clostridioides difficile infection (CDI) is a principal cause of hospital-acquired infections and
fatalities worldwide. The need for new, more potent anticlostridial agents is far from being …

Clostridium difficile (C. difficile) is one of the most threatening bacteria globally, causing high
mortality and morbidity in humans and animals, and is considered a public health threat that …

Prior work has shown a positive scaling relationship between vertebrate body size and gut
microbiome alpha-diversity. This observation mirrors commonly observed species area …